Perspective Therapeutics (CATX) Current Assets (2011 - 2026)

Perspective Therapeutics has disclosed Current Assets across 16 years of filings, most recently posting $275.4 million for Q1 2026.

• Current Assets for Q1 2026 came in at $275.4 million, up 27.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $275.4 million (up 27.63% YoY), and the FY2025 annual result was $148.4 million, down 35.81% from the prior year.
• Current Assets came in at $275.4 million for Q1 2026 at Perspective Therapeutics, up from $148.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $294.2 million in Q2 2024 to a low of $16.8 million in Q4 2023.
• The 5-year median for Current Assets is $148.4 million (2025), against an average of $137.7 million.
• Across the five-year window, Current Assets plunged 68.36% in 2023 and soared 1272.93% in 2024, its largest moves.
• Perspective Therapeutics' Current Assets stood at $53.2 million in 2022, then slumped by 68.36% to $16.8 million in 2023, then jumped by 1272.93% to $231.2 million in 2024, then slumped by 35.81% to $148.4 million in 2025, then jumped by 85.56% to $275.4 million in 2026.
• The last three Current Assets figures came in at $275.4 million (Q1 2026), $148.4 million (Q4 2025), and $178.5 million (Q3 2025), per Business Quant data.